DRW Securities’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $231K | Buy |
+440
| New | +$231K | 0.01% | 750 |
|
|
2024
Q4 | – | Sell |
-228
| Closed | -$240K | – | 618 |
|
|
2024
Q3 | $240K | Sell |
228
-1
| -0.4% | -$1.05K | 0.01% | 398 |
|
|
2024
Q2 | $241K | Sell |
229
-589
| -72% | -$619K | 0.01% | 342 |
|
|
2024
Q1 | $766K | Buy |
+818
| New | +$766K | 0.02% | 142 |
|
|
2023
Q4 | – | Sell |
-477
| Closed | -$393K | – | 359 |
|
|
2023
Q3 | $393K | Buy |
+477
| New | +$393K | 0.01% | 182 |
|
|
2022
Q2 | – | Sell |
-397
| Closed | -$277K | – | 259 |
|
|
2022
Q1 | $277K | Buy |
+397
| New | +$277K | 0.01% | 132 |
|
|
2021
Q3 | – | Sell |
-567
| Closed | -$317K | – | 273 |
|
|
2021
Q2 | $317K | Buy |
+567
| New | +$317K | 0.01% | 131 |
|
|
2020
Q2 | – | Sell |
-520
| Closed | -$254K | – | 257 |
|
|
2020
Q1 | $254K | Buy |
+520
| New | +$254K | 0.01% | 194 |
|
|
2018
Q1 | – | Sell |
-1,080
| Closed | -$406K | – | 405 |
|
|
2017
Q4 | $406K | Buy |
+1,080
| New | +$406K | 0.04% | 238 |
|